Diagnostic possibilities of laboratory assessment of cathepsin K activity in gingival and peri-implant fluid under normal conditions and periimplantitis

Zorina O.A.

National Medical Research Center for Dental and Maxillofacial Surgery of Ministry of Health of the Russian Federation;
I.M. Sechenov First Moscow State Medical University (Sechenov University)

Amkhadova M.A.

Moscow Regional Research Clinical Institute named after M.F.Vladimirsky

Boriskina O.A.

National Medical Research Center of Dental and Maxillofacial Surgery of Ministry of Health of the Russian Federation;
I.M. Sechenov First Moscow State Medical University (Sechenov University)

Aleskerov E.Sh.

Moscow Regional Research Clinical Institute named after M.F.Vladimirsky

Polyakov V.M.

Rostov State Medical University of Ministry of Health of the Russian Federation

Diagnostic possibilities of laboratory assessment of cathepsin K activity in gingival and peri-implant fluid under normal conditions and periimplantitis

Authors:

Zorina O.A., Amkhadova M.A., Boriskina O.A., Aleskerov E.Sh., Polyakov V.M.

More about the authors

Journal: Stomatology. 2021;100(3): 55‑59

DOI: 10.17116/stomat202110003155

Downloaded: 48

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zorina OA, Amkhadova MA, Boriskina OA, Aleskerov ESh, Polyakov VM. Diagnostic possibilities of laboratory assessment of cathepsin K activity in gingival and peri-implant fluid under normal conditions and periimplantitis. Stomatology. 2021;100(3):55‑59. (In Russ.)
https://doi.org/10.17116/stomat202110003155

Close metadata

OBJECTIVE

The aim of the work was to develop a non-invasive laboratory method for local control of the severity of osteo-destructive processes in the bone tissue of the jaws after dental implantation.

MATERIALS AND METHODS

The study comprised 75 individuals aged 18 to 65. The main group included 40 patients with a diagnosis of dental periimplantitis (ICD K 10.2). A comparison group (n=20) included patients after dental implantation without postoperative complications. The control group (n=25) consisted of individuals without dental pathology. Cathepsin K (CTSK) (Human) ELISA Kit (Cloud-Clone Corp., USA) was used to determine the concentration of cathepsin K by the enzyme immunoassay in the gingival or peri-implant fluid.

RESULTS

The concentration of cathepsin K in the gingival fluid in the patients of the control group was 1.7±0.3 pmol/l, in the comparison group the concentration of the studied biomarker corresponded to 2.3±0.4 pmol/l. In the main group, the concentration of cathepsin K in the exudate of peri-implantation pockets increased 2.8 times (p<0.05) and corresponded to 4.9±0.5 pmol/l. The concentration of cathepsin K in the gingival fluid normally did not depend on age and gender, which increased the independence of the osteomarker for characterizing the osteoresorbent process in the peri-implantation area. After dental implantation, an excess of cathepsin K concentration above the level of 2.7 pmol/l with a diagnostic sensitivity of 82.5% and a specificity of 83.7% suggests a high risk of developing peri-implantitis.

CONCLUSION

The concentration of cathepsin K may be seen as valuable marker for local inflammatory and destructive processes in the contents of the peri-implantation area.

Keywords:

cathepsin K

gingival fluid

dental implantation

periimplantitis

marker of osteoresorption

Authors:

Zorina O.A.

National Medical Research Center for Dental and Maxillofacial Surgery of Ministry of Health of the Russian Federation;
I.M. Sechenov First Moscow State Medical University (Sechenov University)

Amkhadova M.A.

Moscow Regional Research Clinical Institute named after M.F.Vladimirsky

Boriskina O.A.

National Medical Research Center of Dental and Maxillofacial Surgery of Ministry of Health of the Russian Federation;
I.M. Sechenov First Moscow State Medical University (Sechenov University)

Aleskerov E.Sh.

Moscow Regional Research Clinical Institute named after M.F.Vladimirsky

Polyakov V.M.

Rostov State Medical University of Ministry of Health of the Russian Federation

Received:

09.03.2021

Accepted:

15.03.2021

List of references:

Kulakov AA, Kasparov AS, Porfenchuk DA. Factors affecting osteointegration and the use of early functional load to reduce the duration of treatment in dental implantation. Stomatologia. 2019;98(4):107-115. (In Russ.). https://doi.org/10.17116/stomat201998041107
Parfenov AK, Erokina NL, Rogatina TV, Parfenova SV. Analysis of complications of the surgical stage of dental implantation. Dental Forum. 2019; 4(75):82-83. (In Russ.).
Kostina IN, Yakov AYu, Kostin AO. Peri-implant mucositis and peri-implantitis: epidemiology, modern understanding of the clinic and diagnosis. Dental’naya implantologiya i hirurgiya. 2020;3/4(40/41):50-57. (In Russ.).
Dai R, Wu Z, Chu HY, Lu J, Lyu A, Liu J, Zhang G. Cathepsin K: The Action in and Beyond Bone. Front Cell Dev Biol. 2020;8:433. https://doi.org/10.3389/fcell.2020.00433
Takito J, Inoue S, Nakamura M. The sealing zone in osteoclasts: a self-organized structure on the bone. Int J Mol Sci. 2018;19:984. https://doi.org/10.3390/ijms19040984
Lu J, Wang M, Wang Z, Fu Z, Lu A, Zhang G. Advances in the discovery of cathepsin K inhibitors on bone resorption. J Enzyme Inhib Med Chem. 2018; 33:890-904. https://doi.org/10.1080/14756366.2018.1465417
Yu J, Adapala NS, Doherty L, Sanjay A. Cbl-PI3K interaction regulates Cathepsin K secretion in osteoclasts. Bone. 2019;127;376-385. https://doi.org/10.1016/j.bone.2019.07.009
Zorina OA, Amhadova MA, Hamukova AA, Aleskerov ESh, Ajrapetov GA, Demidova AA. Osteoimmunological aspects of periodontal inflammatory destructive changes at periimplantitis, chronic periodontitis and oncological diseases of the oral cavity. Stomatologia. 2020;99(4):27-32. (In Russ.). https://doi.org/10.17116/stomat20209904127
Lee K, Seo I, Choi MH, Jeong D. Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology. Int J Mol Sci. 2018;19:3004. https://doi.org/10.3390/ijms19103004
Tanaka M, Hashimoto Y, Hasegawa C, Deacon S, Eastell R. Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis. BMC Musculoskelet Disord. 2017;18:267. https://doi.org/10.1186/s12891-017-1625-y
Lyubimova NV, Kushlinskij NE. Biochemical markers of bone metastasis. Uspekhi molekulyarnoj onkologii. 2015;1(2):61-75. (In Russ.). https://doi.org/10.17650/2313-805X.2015.2.1.061-075
Borggaard XG, Pirapaharan DC, Delaisse J-M, Soe K. Osteoclasts’ Ability to Generate Trenches Rather Than Pits Depends on High Levels of Active Cathepsin K and Efficient Clearance of Resorption Products. Int J Mol Sci. 2020;21:5924. https://doi.org/10.3390/ijms21165924
Tsoriev TT, Belaya ZE, Rozhinskaya LY, Mel’nichenko GA, Ilyin AV, Nikankina LV, Dedov II. New biomarkers of bone remodelling regulation in patients with acromegaly and endogenous hypercortisolism. Ozhirenie i metabolism. 2018;15(3):33-41. (In Russ.). https://doi.org/10.14341/OMET9447
McClung MR, O’Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diabetes Endocrinol. 2019;7: 899-911. https://doi.org/10.1016/S2213-8587(19)30346-8
Tsoriev TT, Grebennikova TA, Ilyin AV, et al. Cathepsin K level in patients with Itsenko—Cushing’s disease as a new marker of osteoclast activity. In: Dostizheniya personalizirovannoy meditsiny segodnya — rezul’tat prakticheskogo zdravookhraneniya zavtra. VII Russian Congress of Endocrinologists Abstract Book; 2016 Mar 2—5. Moscow, Russia. M. 2016;348. (In Russ.).
Drake MT, Clarke BL, Oursler MJ, Khosla S. Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev. 2017;38:325-350. https://doi.org/10.1210/er.2015-1114
Safronenko AV, Kosenko VA, Demidova AA, Demidov IA, Sukhorukova NV, Gantsgorn EV. Information Algorithm for Non-Invasive Evaluation of Osteoresorbable Side Effects of Glucocorticosteroids in Patients with Ulcerative Colitis. Journal Biomed. 2020;16(3):92-96. (In Russ.). https://doi.org/10.33647/2074-5982-16-3-92-96
Bonnet N, Brun J, Rousseau JC, Duong LT, Ferrari SL. Cathepsin K controls cortical bone formation by degrading periostin. J Bone Miner Res. 2017;32:1432-1441. https://doi.org/10.1002/jbmr.3136

Close metadata